Biotechnology and Pharmaceuticals are the two important pillars when it comes to medicine and treatments. In both of these industries, Marc Beer thrives get the best treatments and technologies that he can contribute to the community. ViaCell is a company founded by Marc Beer that specializes in the preservation, collection, and development of umbilical cord blood stem cells. Beer stayed in the company for seven years to see through it that it will end up successful. The company was acquired by PerkinElmer last 2007. Although ViaCell was acquired, Beer founded Renovia and managed to capture a lot of interest. Learn more: https://www.crunchbase.com/person/marc-beer
Marc Beer is currently the chairman of the board of directors in Good Start Genetics. Also, as a founding chairman, he leads Minerva Neurosciences Inc. With his knowledge, he fulfills his duty as a member of the Miami University Business Advisory Council. Gathering a lot of experience during his 25-year tenure in biotechnology and pharmaceuticals, he decided to create Renovia last August 2016. Renovia is currently headed by him, Ramon Iglesias, MD, and Yolanda Lorie. Renovia currently managed to get a series B funding and venture debt worth $42 million approved for a new product with the help of The Longwood Fund. With a new challenge in sight, Renovia aims to treat pelvic floor disorders.
Pelvic Floor Disorders, as the name suggests are disorders that affect the pelvic floor. The pelvic floor is an area inside the body that contains ligaments, tissues, and the urinary tract. One of its examples, the urinary incontinence, is affecting 250 million women globally. Because of disregard in diagnosis, a lot more is expected to be undiagnosed and affected. Renovia’s answer to this is the Leva product line which aims to cure the one-quarter of women worldwide who suffers from pelvic floor disorders.
Leva is Renovia’s hope to cure a lot of cases of pelvic floor disorders. The method of treating the pelvic floor is by strengthening it via muscles rehabilitation. The rehabilitation is aided by a technology that uses Bluetooth and an app exclusively made for Leva. This treatment is being developed in order to create a medication and treatment that will not involve surgery. As of now, Renovia is developing four products that would focus on the therapy and diagnosis, and Leva is among those products.
Marc Beer stated in a media conference that he and his team from Renovia are grateful for the investors who are currently helping him make his vision come true. With Leva, the diagnosis and treatment of Pelvic Floor Disorder will be easier, and Beer is expecting this to make more awareness. By combining digital and sensor technology, a revolutionized technology will emerge and will uncover more about the Pelvic Floor Disorder